31
Participants
Start Date
March 31, 2013
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
Ipilimumab
Chemotherapy
Lehigh Valley Hospital, Allentown
Local Institution, Kiel
Local Institution, Bordeaux
Birmingham Hematology & Oncology Associates Llc, Birmingham
Local Institution, Göttingen
Local Institution, Nantes
Investigative Clinical Research Of Indiana, Llc, Indianapolis
Local Institution, Cologne
Local Institution, Siena
Cancer Center Of Kansas, Wichita
Local Institution, Heidelberg
Local Institution, Paris
Texas Oncology Sammons Cancer Center, Dallas
Rocky Mountain Cancer Centers, Aurora
Comprehensive Cancer Center Of Nevada, Las Vegas
Local Institution, Erfurt
Local Institution, Vienna
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY